| Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... autophagy 17 (1), 1-382, 2021 | 10692 | 2021 |
| Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial HC Gerstein, HM Colhoun, GR Dagenais, R Diaz, M Lakshmanan, P Pais, ... The Lancet 394 (10193), 121-130, 2019 | 2237 | 2019 |
| Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial HC Gerstein, HM Colhoun, GR Dagenais, R Diaz, M Lakshmanan, P Pais, ... The Lancet 394 (10193), 131-138, 2019 | 531 | 2019 |
| A role for myosin VII in dynamic cell adhesion RI Tuxworth, I Weber, D Wessels, GC Addicks, DR Soll, G Gerisch, ... Current Biology 11 (5), 318-329, 2001 | 196 | 2001 |
| Dysregulation of autophagy as a common mechanism in lysosomal storage diseases E Seranova, KJ Connolly, M Zatyka, TR Rosenstock, T Barrett, ... Essays in biochemistry 61 (6), 733-749, 2017 | 170 | 2017 |
| Dictyostelium RasG Is Required for Normal Motility and Cytokinesis, But Not Growth RI Tuxworth, JL Cheetham, LM Machesky, GB Spiegelmann, G Weeks, ... The Journal of cell biology 138 (3), 605-614, 1997 | 148 | 1997 |
| Unconventional myosins: anchors in the membrane traffic relay RI Tuxworth, MA Titus Traffic 1 (1), 11-18, 2000 | 104 | 2000 |
| The Batten disease gene CLN3 is required for the response to oxidative stress RI Tuxworth, H Chen, V Vivancos, N Carvajal, X Huang, G Tear Human molecular genetics 20 (10), 2037-2047, 2011 | 70 | 2011 |
| Interactions between the juvenile Batten disease gene, CLN3, and the Notch and JNK signalling pathways RI Tuxworth, V Vivancos, MB O'Hare, G Tear Human molecular genetics 18 (4), 667-678, 2009 | 61 | 2009 |
| Identification of a myosin VII-talin complex RI Tuxworth, S Stephens, ZC Ryan, MA Titus Journal of Biological Chemistry 280 (28), 26557-26564, 2005 | 50 | 2005 |
| Asymmetric localisation of Miranda and its cargo proteins during neuroblast division requires the anaphase-promoting complex/cyclosome C Slack, PM Overton, RI Tuxworth, W Chia Oxford University Press for The Company of Biologists Limited 134 (21), 3781 …, 2007 | 47 | 2007 |
| The neuronal ceroid lipofuscinoses: Opportunities from model systems KME Faller, R Gutierrez-Quintana, A Mohammed, AA Rahim, RI Tuxworth, ... Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1852 (10 …, 2015 | 43 | 2015 |
| Modification of the Drosophila model of in vivo Tau toxicity reveals protective phosphorylation by GSK3β G Povellato, RI Tuxworth, DP Hanger, G Tear Biology Open 3 (1), 1-11, 2013 | 36 | 2013 |
| The contribution of multicellular model organisms to neuronal ceroid lipofuscinosis research RJ Huber, SM Hughes, W Liu, A Morgan, RI Tuxworth, C Russell Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1866 (9), 165614, 2020 | 29 | 2020 |
| Attenuating the DNA damage response to double-strand breaks restores function in models of CNS neurodegeneration RI Tuxworth, MJ Taylor, A Martin Anduaga, A Hussien-Ali, ... Brain Communications 1 (1), fcz005, 2019 | 26 | 2019 |
| Continuous tracking of startled Drosophila as an alternative to the negative geotaxis climbing assay MJ Taylor, RI Tuxworth Journal of neurogenetics 33 (3), 190-198, 2019 | 20 | 2019 |
| In vivo localization of the neuronal ceroid lipofuscinosis proteins, CLN3 and CLN7, at endogenous expression levels A Mohammed, MB O'Hare, A Warley, G Tear, RI Tuxworth Neurobiology of disease 103, 123-132, 2017 | 17 | 2017 |
| The neuronal ceroid lipofuscinosis protein Cln7 functions in the postsynaptic cell to regulate synapse development KJ Connolly, MB O’Hare, A Mohammed, KM Aitchison, NC Anthoney, ... Scientific Reports 9 (1), 15592, 2019 | 14 | 2019 |
| Inhibition of Chk2 promotes neuroprotection, axon regeneration, and functional recovery after CNS injury MJ Taylor, AM Thompson, S Alhajlah, RI Tuxworth, Z Ahmed Science Advances 8 (37), eabq2611, 2022 | 12 | 2022 |
| The brain‐penetrant ATM inhibitor, AZD1390, promotes axon regeneration and functional recovery in preclinical models of spinal cord injury Z Ahmed, RI Tuxworth Clinical and Translational Medicine 12 (7), 2022 | 6 | 2022 |
